Related references
Note: Only part of the references are listed.Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Developments in the treatment of visceral leishmaniasis
Margriet Leontine den Boer et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy
Dinesh Mondal et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
Amphotericin B treatment for Indian visceral leishmaniasis: Response to 15 daily versus alternate-day infusions
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis
Sujit Kumar Bhattacharya et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Amphotericin B treatment for Indian visceral leishmaniasis: Conventional versus lipid formulations
S Sundar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis
V Syriopoulou et al.
CLINICAL INFECTIOUS DISEASES (2003)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: A multicenter study
S Sundar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Share Paper
